 |
Acta Cytol
- LONGATTO-FILHO A, Schmitt FC
Ongoing Challenges in Maintaining the Diagnostic Quality of Cervical
Cytopathology: Is It Possible to Minimize Differences in Morphological
Interpretations?
Acta Cytol. 2026;70:40-45.
PubMed
Abstract available
- EDVARDSSON H, Dillner J
Human Papillomavirus Primary Screening and Collaboration in Quality Assurance
Work between Laboratories.
Acta Cytol. 2026;70:46-51.
PubMed
Abstract available
- KHOLOVA I
Not Enough Cells: How Insufficient Cytological Specimens Are Mirrored by
Reporting Systems - Journey from the Bethesda to the WHO Reporting Systems.
Acta Cytol. 2026;70:72-83.
PubMed
Abstract available
- HARINATH L, Bai X, Minkowitz J, Zeng X, et al
Artificial Intelligence in Gynecologic Cytology.
Acta Cytol. 2026;70:52-71.
PubMed
Abstract available
Afr J Prim Health Care Fam Med
- POLANE MG, Dlamini SB
A qualitative study exploring the primary health care nurses' lived experiences
of cervical cancer screening.
Afr J Prim Health Care Fam Med. 2026;18:e1-e9.
PubMed
Abstract available
Anal Chem
- PANG S, Jian X, Wei W, Chen Y, et al
Phosphoproteins Identification on Stretchable Photonic Crystal for Cervical
Cancer Assessment.
Anal Chem. 2026 Feb 6. doi: 10.1021/acs.analchem.5c05791.
PubMed
Abstract available
Ann Intern Med
- WENTZENSEN N, Egemen D
Adapting Cervical Cancer Screening in Vaccinated Populations: Individualized
Versus Population-Based Approaches.
Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05559.
PubMed
-
Summary for Patients: Optimizing Cervical Cancer Screening by Age at Vaccination
for Human Papillomavirus.
Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
PubMed
- PEDERSEN K, Di Silvestre J, Sy S, Portnoy A, et al
Optimizing Cervical Cancer Screening by Age at Vaccination for Human
Papillomavirus: Health and Resource Implications.
Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
PubMed
Abstract available
Ann Surg Oncol
- WANG Q, Su M, Zheng Y
The Application of Tumor-Free Technique in Robotic Single-Site Radical
Hysterectomy for Early Stage Cervical Cancer.
Ann Surg Oncol. 2026 Feb 5. doi: 10.1245/s10434-025-19026.
PubMed
Abstract available
Anticancer Res
- SAGER G, Livik M, Hellevik T, Orbo A, et al
Extracellular cGMP Levels Predict the Response of C4-1 Cervical Cancer Cells to
Ionizing Radiation.
Anticancer Res. 2026;46:611-618.
PubMed
Abstract available
Aust N Z J Obstet Gynaecol
- ALLIN T, Taunton C, Ketchell F, Hempenstall A, et al
High Cervical Cancer Screening Rates and Low Human Papillomavirus Detection in
the Remote Torres Strait, Far North Queensland.
Aust N Z J Obstet Gynaecol. 2026;66:e70060.
PubMed
Abstract available
- TRAN CT, Wang M, Plymoth M, Chen J, et al
Accuracy of Self-Reported Cervical Screening Status Among Pregnant Women.
Aust N Z J Obstet Gynaecol. 2025 Nov 26. doi: 10.1111/ajo.70057.
PubMed
Abstract available
BMC Cancer
- FEI C, Chen W, Liu J, Wang J, et al
A real-world multicenter study on opportunistic cervical cancer screening in
hospital in China: comparison of TruScreen device, cytology, and HPV testing for
detecting high-grade cervical lesions.
BMC Cancer. 2026 Feb 4. doi: 10.1186/s12885-026-15590.
PubMed
BMC Infect Dis
- SHI L, Gao X, Huang L, Gao Z, et al
Efficacy, safety and immunogenicity of a recombinant human papillomavirus
bivalent (types 16, 18) vaccine in healthy 18-30-year-old Chinese women: a phase
III, double-blind, randomized, controlled trial.
BMC Infect Dis. 2025;26:248.
PubMed
Abstract available
BMC Med
- YI H, Huang J, Zhang N, Sundquist J, et al
The association of post-conization pregnancy with subsequent cervical lesions:
evidence from a nationwide cohort in Sweden.
BMC Med. 2025;24:61.
PubMed
Abstract available
BMC Med Imaging
- JIANG N, Xin Z, Zhang Y, Liu Y, et al
Clinical translation of a DWI-radiomics nomogram integrating serum biomarkers for
pretreatment staging of cervical cancer.
BMC Med Imaging. 2026 Jan 30. doi: 10.1186/s12880-026-02175.
PubMed
BMC Public Health
- SHAHRY P, Mohammadi Khoshoei Z, Cheraghi M, Talaiezadeh A, et al
Population-based epidemiological study of cervical cancer in Khuzestan province,
Iran (2014-2019).
BMC Public Health. 2026 Jan 31. doi: 10.1186/s12889-026-26428.
PubMed
BMC Womens Health
- AYSI?N N, Kurt Can E, Koltas S, Yilmaz M, et al
A qualitative study on the experiences of stigmatisation and spiritual coping
among women diagnosed with cervical cancer in Turkey.
BMC Womens Health. 2026 Feb 2. doi: 10.1186/s12905-026-04318.
PubMed
- AHADI L, Zarei F, Kazemnejad A
From screen to screening: a randomized controlled trial on mHealth vs.
traditional training on knowledge, attitudes, practice, self-efficacy, and
adherence intention to pap smear.
BMC Womens Health. 2025;26:61.
PubMed
Abstract available
BMJ
- TIAN X, Cao C, Wang L, Zhang J, et al
Testing menstrual blood for human papillomavirus during cervical cancer screening
in China: cross sectional population based study.
BMJ. 2026;392:e084831.
PubMed
Abstract available
- WISE J
Cervical cancer: Fewer screening tests needed, study suggests.
BMJ. 2026;392:s224.
PubMed
BMJ Open
- NIRMALKAR AP, Mamulwar M, Godbole S, Shahabuddin SM, et al
Cost-effectiveness of cervical cancer screening among women living with HIV in
India: study protocol.
BMJ Open. 2026;16:e108752.
PubMed
Abstract available
Bull Cancer
- CHARGARI C, Martinez A, Michels J, Lecuru F, et al
[French recommendations for clinical practice, Nice-Saint-Paul-de-Vence
2024-2025: Management of localized cervical cancer].
Bull Cancer. 2026 Jan 29:S0007-4551(26)00025.
PubMed
Abstract available
- SABATIER R, Hennequin C, Martin-Babau J, Follana P, et al
[French recommendations for clinical practice, Nice-Saint-Paul de Vence
2024-2025: Management of advanced cervical cancer].
Bull Cancer. 2026 Jan 30:S0007-4551(26)00022.
PubMed
Abstract available
Cancer
- TAMRAKAR VK, Sharma K, Singh P, Bhargava A, et al
Cervical cancer elimination in India: Repurposing diagnostics, vaccination, and
accelerating policy for the 2030 target.
Cancer. 2026;132:e70292.
PubMed
Abstract available
Cancer Causes Control
- AGYEMAN AA, Bader G, Opoku NKO
The impact of human papillomavirus vaccination implementation in reducing
cervical cancer in a heterosexual population.
Cancer Causes Control. 2026;37:42.
PubMed
Abstract available
- LOOS G, Duclos M, Ennequin G
Physical activity and exercise in cervical cancer: a state-of-the-art review.
Cancer Causes Control. 2026;37:41.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
- CONTRERAS GARDUNO S, Saraiba-Rabanales V, Chavarri-Guerra Y, Soto-Perez-de-Celis E, et al
Trends in Cervical Cytology Test Reports and Cervical Dysplasia Severity
according to Social Deprivation in Mexico (2013-2019): An Analysis of a National
Database.
Cancer Epidemiol Biomarkers Prev. 2026;35:341-347.
PubMed
Abstract available
Cancer Lett
- RUAN J, Gao C, Wang R, Hu B, et al
A novel dual-effect bimodal chip cancer research platform: Chips system
interconnected vascularized tumor organoids culture with real-time exploration
and detection from bench to bedside.
Cancer Lett. 2026;640:218110.
PubMed
Abstract available
Cardiology
- HULLON D, Kara Damor D, Singh T, ALKhatib M, et al
The Overlay of Cervical Cancer with Cardiac Metastasis.
Cardiology. 2026 Feb 2:1-22. doi: 10.1159/000550823.
PubMed
Abstract available
Clin Nucl Med
- YANG L, Zou Y, Tian R
Cervical Paraganglioma Negative on Both 68Ga-DOTATATE and 18F-FDG PET/CT Studies.
Clin Nucl Med. 2025 Apr 24. doi: 10.1097/RLU.0000000000005895.
PubMed
Abstract available
Crit Rev Oncol Hematol
- PARIDA P, Mehta A, Raj EA, Guruvare S, et al
Diagnostic and prognostic significance of circulating HPV cfDNA in cervical
cancer: A systematic review and meta-analysis.
Crit Rev Oncol Hematol. 2026;220:105161.
PubMed
Abstract available
Curr Issues Mol Biol
- VIDALINA D, Ghali L, Kassouf N, Li S, et al
The Therapeutic Effect of EZH2 Inhibitors in Targeting Human Papillomavirus
Associated Cervical Cancer.
Curr Issues Mol Biol. 2025;47:990.
PubMed
Abstract available
- LEI X, Yang W, Xu S, Wu H, et al
Regulation of Energy Metabolism and Lipid Metabolites by IMP3 in Cervical Cancer.
Curr Issues Mol Biol. 2025;47:1014.
PubMed
Abstract available
- ZHOU Z, Li J, Zhao X, Xu H, et al
Gramine Suppresses Cervical Cancer by Targeting CDK2: Integrated
Omics-Pharmacology and In Vitro Evidence.
Curr Issues Mol Biol. 2026;48:64.
PubMed
Abstract available
Cytotechnology
- ZHANG J, Shen J, Yuan L
Effect of HOXB7 in promoting proliferation, invasion and migration of cervical
cancer cells.
Cytotechnology. 2026;78:38.
PubMed
Abstract available
Diagn Cytopathol
- OZDEMIR CY, Marangoz B, Ozdemir N, Cicekli N, et al
Clinical Outcomes and Risk Implications of HPV 31 Infection: A 10-Year
Retrospective Cohort Study.
Diagn Cytopathol. 2026;54:167-172.
PubMed
Abstract available
- HARINATH L, Matsko J, Colaizzi A, Elishaev E, et al
Morphologic Evaluation of Hyperchromatic Crowded Groups Present in Cervical Thin
Prep Cytology Tests as Identified by the Hologic Genius Digital Diagnostics
System: A Descriptive Study.
Diagn Cytopathol. 2026;54:173-183.
PubMed
Abstract available
Dtsch Arztebl Int
- SCHWAB R, Emrich K, Heimes AS, Schwarzer K, et al
Combined Cervical Cancer Screening and the Incidence of Adenocarcinoma: An
Analysis of Data From the German Cancer Registries.
Dtsch Arztebl Int. 2026;.
PubMed
Abstract available
Front Cell Infect Microbiol
- PENG L, Yu S, Dong Y, Gu H, et al
A potential association between the characteristics of the multi-organ microbiota
and lymph node metastasis in cervical cancer.
Front Cell Infect Microbiol. 2026;15:1639811.
PubMed
Abstract available
Front Genet
- SHEN Y, Kang M
Retrospective analysis of preoperative serum tumor marker levels and their
correlation with pathological characteristics and prognosis in cervical cancer
patients.
Front Genet. 2026;17:1724789.
PubMed
Abstract available
Front Oncol
- ZHANG Y, Yuan J, Chen L
Transforming cervical cancer pathological diagnosis through artificial
intelligence: progress, performance, and barriers to clinical implementation.
Front Oncol. 2026;15:1716018.
PubMed
Abstract available
Front Public Health
- SHEN X, Guo W, Yao C, Wu H, et al
Epidemiological analysis of human papillomavirus and its subtype infections in
36,248 women in Wuhan, China.
Front Public Health. 2026;14:1745604.
PubMed
Abstract available
Gynecol Oncol Rep
- ROTHSCHILD H, Keverline K, McKinney S, Farrell M, et al
From #cervicalcancerscreening to #LEEP - Quality and accuracy of cervical cancer
content on TikTok.
Gynecol Oncol Rep. 2025;63:102018.
PubMed
Abstract available
Health Expect
- NEWHOUSE R, McWilliams L, Baker-Rand H, Cullimore V, et al
Investigating the Acceptability of Cervical Screening and Self-Sampling in
Postnatal Women at the 6-Week Postnatal Check-Up: A Qualitative Study.
Health Expect. 2026;29:e70582.
PubMed
Abstract available
Health Psychol Rev
- DOU J, Liu Z
Mapping interventions to increase uptake of breast and cervical cancer screening
along the Intervention Ladder: a systematic review.
Health Psychol Rev. 2026 Feb 4:1-30. doi: 10.1080/17437199.2026.2623887.
PubMed
Abstract available
Hum Vaccin Immunother
- RAJAIE S, Emamgholipour S, Azari S, Karimi Z, et al
Acceptance and the willingness to pay for human papilloma virus (HPV) vaccine: A
systematic review.
Hum Vaccin Immunother. 2026;22:2609345.
PubMed
Abstract available
- MABROUK NOUH F, Abualruz H, Al-Zoubi M, Al-Mugheed K, et al
Nursing students' knowledge and attitudes toward human papillomavirus vaccination
and infection.
Hum Vaccin Immunother. 2026;22:2609329.
PubMed
Abstract available
Indian J Med Res
- JOSTEN K, Rose Dhar R, Reshmi B, Natti Krishna V, et al
Barriers to HPV vaccination among adolescent girls in India: A scoping review.
Indian J Med Res. 2026;162:743-753.
PubMed
Abstract available
Indian J Public Health
- HARIPRASAD R, Bhatnagar T
A Systematic Framework for Evaluating Cervical Cancer Screening Programs:
Innovative Approaches and Best Practices.
Indian J Public Health. 2026;70.
PubMed
Abstract available
Infect Disord Drug Targets
- GUIDOBALDI L, Cafiero C, Stillitano G, Ricciardi E, et al
Cervical Cancer Complexity: Exploring the Coexistence of CIN3 and Glandular
Lesions.
Infect Disord Drug Targets. 2026.
PubMed
Abstract available
Int Immunopharmacol
- GHOLAMI S, Aghbash PS, Ravanlo ZZ, Rahimi SB, et al
Therapeutic targeting of the HPV E7 oncoprotein: Current advances and emerging
strategies.
Int Immunopharmacol. 2026;172:116193.
PubMed
Abstract available
Int J Cancer
- RASMUSSEN RMW, Munk C, Kjaer SK
Is the beneficial effect of multi-cohort HPV vaccination on cervical cancer and
precancerous lesions seen across all educational levels?
Int J Cancer. 2026 Feb 6. doi: 10.1002/ijc.70360.
PubMed
Abstract available
Int J Clin Oncol
- KAIDO Y, Kagabu M, Chiba Y, Sato S, et al
Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy
following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical
cancer: a multicenter retrospective study.
Int J Clin Oncol. 2026 Jan 30. doi: 10.1007/s10147-026-02971.
PubMed
Abstract available
Int J Gynecol Cancer
- SARDINHA TG, Vale DB, Discacciati MG, Triglia RM, et al
Diagnostic performance and clinical utility of p16 immunostaining in a
population-based HPV DNA screening program.
Int J Gynecol Cancer. 2026;36:104451.
PubMed
Abstract available
- ELMEHRATH AO, Njala B, Sakala D, Nogueras-Gonzalez GM, et al
Demographic and social determinants of human immunodeficiency virus status among
women with cervical cancer in a low-resource setting.
Int J Gynecol Cancer. 2025 Dec 26:102867. doi: 10.1016/j.ijgc.2025.102867.
PubMed
Abstract available
- HEMIDA R, Barakat R, Nabil H, Hasan M, et al
Retraction notice to "Cervical cancer elimination in low-resource countries:
low-cost strategy" [International Journal of Gynecological Cancer, Volume 35
Issue 9 (2025) 101828].
Int J Gynecol Cancer. 2026;36:104540.
PubMed
- YONEMORI K, Nishio S, Suzuki S, Hasegawa K, et al
Tisotumab vedotin in Japanese patients with recurrent or metastatic cervical
cancer: results from the innovaTV 301/ENGOT-cx12/GOG-3057 trial.
Int J Gynecol Cancer. 2025 Dec 31:104450. doi: 10.1016/j.ijgc.2025.104450.
PubMed
Abstract available
- CIANCIA M, Moro F, Mascilini F, Testa AC, et al
Response to the Correspondence by Peng et al. on "Diagnostic performance of
ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer
after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
Int J Gynecol Cancer. 2026 Jan 18:104499. doi: 10.1016/j.ijgc.2026.104499.
PubMed
- O'SHEA J, Yu K, Chang D, Khaw P, et al
Survival and patterns of failure in small cell neuroendocrine carcinoma of the
cervix treated with definitive chemoradiotherapy.
Int J Gynecol Cancer. 2026;36:102874.
PubMed
Abstract available
- SEO JH, Chung YE, Lim S, Kim SY, et al
Pre-diagnostic physical activity and mortality in cervical cancer: a nationwide
cohort study.
Int J Gynecol Cancer. 2026 Jan 16:104477. doi: 10.1016/j.ijgc.2026.104477.
PubMed
Abstract available
- KOBAYASHI M, Yao JA, Lee MW, Nakagawa S, et al
Relative survival of large cell to small cell neuroendocrine carcinoma of the
uterine cervix.
Int J Gynecol Cancer. 2026;36:102852.
PubMed
Abstract available
Int J Prev Med
- TJALMA WA
Rare Today, Common Tomorrow: Strengthening Cervical Cancer Prevention in
Low-Incidence Countries is Urgently Needed.
Int J Prev Med. 2025;16:85.
PubMed
iScience
- WANG X, Wang Q, Ding G, Wang J, et al
Artificial intelligence for colposcopic and cytological image analysis in early
cervical cancer detection.
iScience. 2026;29:114627.
PubMed
Abstract available
J Biochem Mol Toxicol
- KAYA M, Kara Y, Sanli-Mohamed G
Anticancer Properties of Newly Synthesized Pyrrole Derivatives as Potential
Tyrosine Kinase Inhibitors.
J Biochem Mol Toxicol. 2026;40:e70665.
PubMed
Abstract available
J Cancer Policy
- ADANKWAH E, Mensah ABB, Konney T, Nones M, et al
A pilot study on the acceptability and feasibility of HPV self-sampling for
cervical cancer screening among women attending urban hospitals in Kumasi, Ghana.
J Cancer Policy. 2026 Jan 30:100710. doi: 10.1016/j.jcpo.2026.100710.
PubMed
Abstract available
J Clin Ultrasound
- WANG Z, Luo H
Diagnostic Value of Ultrasound in Primary Cervical Ewing's Sarcoma: Two Case
Reports and Literature Review.
J Clin Ultrasound. 2026;54:490-498.
PubMed
Abstract available
J Ethnopharmacol
- CHEN J, Wu M, Zhang R, Cao Y, et al
Luteolin, a Bioactive Compound from Celastrus orbiculatus Stem, Inhibits Cervical
Cancer via CA2 Suppression: A Translational Study Bridging Basic Research and
Clinical Application.
J Ethnopharmacol. 2026 Feb 4:121326. doi: 10.1016/j.jep.2026.121326.
PubMed
Abstract available
J Obstet Gynaecol
- XIA W, Wang J, Yang X, Sha Y, et al
DNA methylation triage of human papillomavirus-positive atypical squamous cells
of undetermined significance in cervical cancer screening.
J Obstet Gynaecol. 2026;46:2623828.
PubMed
Abstract available
J Public Health Afr
- CHEPKORIR J, Kivuti-Bitok L, Perrin N, Gross D, et al
Cervical cancer information access and dissemination strategies among rural
Kenyan women: A mixed methods study.
J Public Health Afr. 2026;17:1457.
PubMed
Abstract available
JAMA Health Forum
- ZHANG L, Zhang S, Liu S, Jian W, et al
Human Papillomavirus Vaccination Policies and Discourse on Social Media.
JAMA Health Forum. 2026;7:e256425.
PubMed
Abstract available
JAMA Netw Open
- FOKOM DOMGUE J, Chandra M, Oladoyin O, Desai M, et al
Women's Preferences for Home-Based Self-Sampling or Clinic-Based Testing for
Cervical Cancer Screening.
JAMA Netw Open. 2026;9:e2558841.
PubMed
Abstract available
Lakartidningen
- MILERAD H, Bonander C, Nordqvist Kleppe S, Dillner J, et al
[Geomapping of 10-year coverage rate of cervical cancer screening in Sweden - a
basis for targeting population-level interventions to improve screening].
Lakartidningen. 2026;123:25052.
PubMed
Abstract available
Lancet HIV
- DALAL S, Sundstrom K, Silva R, Taghavi K, et al
Age-specific distribution of cervical precancer and cancer among women living
with HIV across seven countries: a systematic review and an individual patient
data meta-analysis.
Lancet HIV. 2026;13:e126-e137.
PubMed
Abstract available
Lancet Public Health
- SMITH MA, Killen J, Jamieson L, O'Farrell X, et al
Accelerating cervical cancer elimination in Aboriginal and Torres Strait Islander
women: a modelling study.
Lancet Public Health. 2026 Feb 3:S2468-2667(26)00005.
PubMed
Abstract available
Mamm Genome
- LU X, Yao L, Xu X, Rexiti MG, et al
m5c-modified LINC01094 participates in epithelial-mesenchymal transition and
metastasis of cervical cancer cells via the ZNF582-SIRT1/p53 axis.
Mamm Genome. 2026;37:32.
PubMed
Abstract available
Med Oncol
- YANG J, Shi Z, Song T, Shao Y, et al
LncRNA TMPO-AS1 aggravates the cisplatin resistance in cervical cancer via
miR-140-5p/DNMT1 axis-mediated DNA methylation of KLK10.
Med Oncol. 2026;43:136.
PubMed
Abstract available
Med Phys
- PENG Z, Liu C, Tang D, Li S, et al
Slice-prompted HR-CTV interactive segmentation for cervical cancer brachytherapy:
A multi-center study.
Med Phys. 2026;53:e70305.
PubMed
Abstract available
medRxiv
- LOU H, Langan D, Syracuse N, Murphy EA, et al
A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway
inhibitors suppress growth and cooperate with HPV-directed immunotherapy.
medRxiv [Preprint]. 2026 Jan 23:2026.01.21.26344562.
PubMed
Abstract available
Microbiol Spectr
- WANG Z, Hu T, Liu W, Zhou H, et al
Development and clinical validation of an ERA-CRISPR/Cas12a assay for the rapid
detection of 14 high-risk HPV types.
Microbiol Spectr. 2026;14:e0303625.
PubMed
Abstract available
Obstet Gynecol Int
- BAHARDOUST M, Ghalavand N, Shamohammadi M, Asl MS, et al
Pretreatment CRP-Albumin-Lymphocyte (CALLY) Index as a Prognostic Biomarker of
Survival and Recurrence-Free Survival in Patients With Early-Stage Cervical
Cancer After Radical Hysterectomy: A Multicenter Retrospective Cohort Study.
Obstet Gynecol Int. 2026;2026:6137796.
PubMed
Abstract available
- WANG R, Liu S, Wang R, Guo Q, et al
Different Expressions and Methylation Patterns of cGAS and STING in Cervical
Cancer.
Obstet Gynecol Int. 2026;2026:2210380.
PubMed
Abstract available
Oncol Lett
- OZGURLUK I, Erdem HB, Alay MT, Oktar O, et al
Unveiling mitochondrial DNA copy number alterations: Insights into progression
from cervical intraepithelial neoplasia to cervical cancer.
Oncol Lett. 2026;31:117.
PubMed
Abstract available
Pan Afr Med J
- ZRAIDI M, Kamel N, El Belloute G, Abidi K, et al
[Obstetrical characteristics related to cervical cancer in the Northern Territory
of the Rabat-Sale-Kenitra Region, Morocco].
Pan Afr Med J. 2025;52:102.
PubMed
- ZHANG F, Hu J, Bian J, Lan Y, et al
Mullerian adenosarcoma mimicking cervical carcinoma in a 79-year-old woman:
diagnostic challenges and laparoscopic treatment: a case report.
Pan Afr Med J. 2025;52:110.
PubMed
Abstract available
Photodiagnosis Photodyn Ther
- ZHANG Z, Kong D, Ding Y, Lu M, et al
Laser ablation combined with photodynamic therapy for complex vaginal HSIL after
repeat cervical conizations: a case report.
Photodiagnosis Photodyn Ther. 2026;57:105267.
PubMed
Abstract available
Phys Imaging Radiat Oncol
- NING B, Li Z, Yu D, Li C, et al
Deep learning and dual-radiomics model incorporating brachytherapy applicator
type to predict radiation-induced acute rectal injury in cervical cancer
patients.
Phys Imaging Radiat Oncol. 2026;37:100908.
PubMed
Abstract available
Radiother Oncol
- SPAMPINATO S, Kutluyer S, Almaz S, Schuur N, et al
Impact of primary radiotherapy on the psychosocial well-being of patients with
locally advanced cervical cancer (IMPRaCC study).
Radiother Oncol. 2026 Jan 30:111405. doi: 10.1016/j.radonc.2026.111405.
PubMed
Abstract available
Res Sq
- RODRIGUEZ NM, Case X, Balian L, Ziolkowski R, et al
Cervical Cancer Screening Rates and Associated Sociodemographic and Behavioral
Factors among People Experiencing Homelessness in Indiana.
Res Sq [Preprint]. 2026 Jan 30:rs.3.rs-8524257. doi: 10.21203/rs.3.rs-8524257.
PubMed
Abstract available
Retrovirology
- JAHANSHAHI S, Soleimani-Jelodar R, Jalilvand S, Shoja Z, et al
Investigation of the expression level of human endogenous retrovirus E env
transcript in cervical cancer.
Retrovirology. 2026 Feb 2. doi: 10.1186/s12977-025-00672.
PubMed
Abstract available
Sci Rep
- TATARNIKOVA I, Talyshev V, Sen'kova A, Markov O, et al
Two paired HPV-59 cervical cancer cell lines with distinct chemoradioresistant
phenotypes.
Sci Rep. 2026 Feb 4. doi: 10.1038/s41598-026-36260.
PubMed
- LEINO A, Numminen E, Kares S, Merio M, et al
Clinical relevance of partial HPV genotyping in cervical cancer screening.
Sci Rep. 2026 Feb 4. doi: 10.1038/s41598-026-36594.
PubMed
Abstract available
- XIE X, Liu C, Liu X, Hou L, et al
Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK
pathways and induction of apoptosis and autophagy.
Sci Rep. 2026;16:5155.
PubMed
Abstract available
Taiwan J Obstet Gynecol
- IMATAKE H, Taki M, Yamanoi K, Murakami R, et al
Healthcare provider bias in cancer treatment decisions for elderly patients.
Taiwan J Obstet Gynecol. 2026;65:29-33.
PubMed
Abstract available
- YANG ST, Chang CW, Wang PH
Clinical impact of glandular involvement in high-grade squamous intraepithelial
lesions of the cervix.
Taiwan J Obstet Gynecol. 2026;65:64-69.
PubMed
Abstract available
Vaccine
- COBLENTZ EG, Packee CR, Ky SL, Brubaker AG, et al
Prioritization of HPV vaccine preventable diseases among emerging adults -
Implications for health education and communication.
Vaccine. 2026;74:128223.
PubMed
Abstract available
FAQ
